Skyrizi 600 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJF8R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,781
Award facts
- Contract value 100% obligated
- $12,781.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Skyrizi 600 mg/10 mL vials with a ceiling value of $12,781.32 and an ultimate completion date of January 26, 2026. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply support under AmerisourceBergen's broader federal contract portfolio. The contract utilizes no set-aside designation, reflecting the contractor's demonstrated capability to compete openly in federal medical procurement. Skyrizi is a prescription medication used to treat certain inflammatory skin conditions, indicating this award addresses specialized pharmaceutical needs within the Defense Health System.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle through December 2026 that enables the contractor to supply a full spectrum of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the location of performance for this delivery order—serves as a critical pharmaceutical distributor for federal agencies including the Defense Health Agency and U.S. Coast Guard. The contractor's extensive portfolio of federal awards demonstrates consistent capability in fulfilling diverse medical supply requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices.
Quick answers
Who was awarded contract SPE2DR26FJF8R?
SPE2DR26FJF8R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26FJF8R worth?
The government has obligated $12,781 on SPE2DR26FJF8R.
Is contract SPE2DR26FJF8R an order under another contract?
Yes. SPE2DR26FJF8R is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJF8R competed?
The extent of competition for SPE2DR26FJF8R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award